Literature DB >> 15733859

The flexible loop of Bcl-2 is required for molecular interaction with immunosuppressant FK-506 binding protein 38 (FKBP38).

Cong Bao Kang1, Jeff Tai, Joel Chia, Ho Sup Yoon.   

Abstract

Bcl-2 contains an unusually long loop between the first and the second helices. This loop has been shown to be highly flexible based on NMR and X-ray crystallographic analyses of this region. Bcl-2 is regulated at the posttranslational level through phosphorylation of specific residues within the flexible loop. The biological role and posttranslational modifications of the loop of Bcl-2 is currently unclear. FK-506 binding protein 38 (FKBP38) has been reported to interact with Bcl-2, suggesting that FKBP38 could act as a docking molecule to localize Bcl-2 at the mitochondrial membrane [Shirane, M. and Nakayama, K.I. (2003) Inherent calcineurin inhibitor FKBP38 targets Bcl-2 to mitochondria and inhibits apoptosis. Nat. Cell Biol. 5, 28-37]. Here, we investigated the molecular interaction between FKBP38 and Bcl-2, and demonstrated that Bcl-2 interacts with FKBP38 through the unstructured loop, and the interaction appears to regulate phosphorylation in the loop of Bcl-2.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15733859     DOI: 10.1016/j.febslet.2005.01.053

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  16 in total

1.  The FKBP38 catalytic domain binds to Bcl-2 via a charge-sensitive loop.

Authors:  Katja Haupt; Günther Jahreis; Miriam Linnert; Mitcheell Maestre-Martínez; Miroslav Malesevic; Arndt Pechstein; Frank Edlich; Christian Lücke
Journal:  J Biol Chem       Date:  2012-04-20       Impact factor: 5.157

2.  An internal EELD domain facilitates mitochondrial targeting of Mcl-1 via a Tom70-dependent pathway.

Authors:  Chiang-Hung Chou; Ru-Shuo Lee; Hsin-Fang Yang-Yen
Journal:  Mol Biol Cell       Date:  2006-07-05       Impact factor: 4.138

3.  Direct control of mitochondrial function by mTOR.

Authors:  Arvind Ramanathan; Stuart L Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

4.  Characterization of a Bcl-XL-interacting protein FKBP8 and its splice variant in human RPE cells.

Authors:  Yan Chen; Paul Sternberg; Jiyang Cai
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04       Impact factor: 4.799

5.  FK506 binding protein 8 peptidylprolyl isomerase activity manages a late stage of cystic fibrosis transmembrane conductance regulator (CFTR) folding and stability.

Authors:  Darren M Hutt; Daniela Martino Roth; Monica A Chalfant; Robert T Youker; Jeanne Matteson; Jeffrey L Brodsky; William E Balch
Journal:  J Biol Chem       Date:  2012-04-02       Impact factor: 5.157

6.  NMR and crystallographic structures of the FK506 binding domain of human malarial parasite Plasmodium vivax FKBP35.

Authors:  Reema Alag; Insaf A Qureshi; Nagakumar Bharatham; Joon Shin; Julien Lescar; Ho Sup Yoon
Journal:  Protein Sci       Date:  2010-08       Impact factor: 6.725

7.  Involvement of BH4 domain of bcl-2 in the regulation of HIF-1-mediated VEGF expression in hypoxic tumor cells.

Authors:  D Trisciuoglio; C Gabellini; M Desideri; Y Ragazzoni; T De Luca; E Ziparo; D Del Bufalo
Journal:  Cell Death Differ       Date:  2011-01-14       Impact factor: 15.828

8.  Molecular dynamics simulations of the Bcl-2 protein to predict the structure of its unordered flexible loop domain.

Authors:  Pawan Kumar Raghav; Yogesh Kumar Verma; Gurudutta U Gangenahalli
Journal:  J Mol Model       Date:  2011-08-25       Impact factor: 1.810

9.  Regulation of mammalian target of rapamycin complex 1 by Bcl-2 and Bcl-XL proteins.

Authors:  Huafei Zou; Yumei Lai; Xuwen Zhao; Gonghong Yan; Dongzhu Ma; Nayra Cardenes; Sruti Shiva; Yongjian Liu; Xiaochun Bai; Yong Jiang; Yu Jiang
Journal:  J Biol Chem       Date:  2013-08-19       Impact factor: 5.157

10.  A short Nur77-derived peptide converts Bcl-2 from a protector to a killer.

Authors:  Siva Kumar Kolluri; Xiuwen Zhu; Xin Zhou; Bingzhen Lin; Ya Chen; Kai Sun; Xuefei Tian; James Town; Xihua Cao; Feng Lin; Dayong Zhai; Shinichi Kitada; Frederick Luciano; Edmond O'Donnell; Yu Cao; Feng He; Jialing Lin; John C Reed; Arnold C Satterthwait; Xiao-kun Zhang
Journal:  Cancer Cell       Date:  2008-10-07       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.